P Alessandrini
Impact in
- Biochemistry top 1%
- Antioxidant Activity and Oxidative Stress
- Eicosanoids and Hypertension Pharmacology
- Nutrition and Dietetics top 2%
- Fatty Acid Research and Health
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Diabetes Treatment and Management 3
-
- Inflammatory mediators and NSAID effects 5
- Co-authors
- Garret A. FitzGerald (2 shared papers)Howard R. Knapp (1 shared paper)Gabriele Bittolo Bon (7 shared papers)Andrea Mezzetti (3 shared papers)Tonino Bucciarelli (3 shared papers)Giovanni Davı̀ (3 shared papers)Carlo Patrono (5 shared papers)Giovanni Ciabattoni (4 shared papers)
- Journals
- Circulation (4 papers)Atherosclerosis (3 papers)New England Journal of Medicine (2 papers)European Journal of Pharmacology (2 papers)Metabolism (2 papers)
- Partner nations
- ItalyUnited StatesCzechia
In The Last Decade
P Alessandrini
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Biochemistry 324
- Biochemistry 232
- Nutrition and Dietetics 424
- Endocrinology, Diabetes and Metabolism 364
- Cardiology and Cardiovascular Medicine 295
Countries citing papers authored by P Alessandrini
This map shows the geographic impact of P Alessandrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Alessandrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Alessandrini more than expected).
Fields of papers citing papers by P Alessandrini
This network shows the impact of papers produced by P Alessandrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Alessandrini. The network helps show where P Alessandrini may publish in the future.
Co-authors
The 25 scholars most cited alongside P Alessandrini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 333 | |
| 2 | 1997 | 302 | |
| 3 | 1998 | 145 | |
| 4 | 2009 | 94 | |
| 5 | 2000 | 85 | |
| 6 | 2009 | 84 | |
| 7 | 2003 | 60 | |
| 8 | 1988 | 54 | |
| 9 | 1999 | 49 | |
| 10 | 2000 | 45 | |
| 11 | 2003 | 43 | |
| 12 | 1985 | 41 | |
| 13 | 2003 | 27 | |
| 14 | 1977 | 22 | |
| 15 | Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. | 1993 | 17 |
| 16 | Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease. | 1991 | 3 |
| 17 | Dynamic liver radionuclide scanning in the evaluation of liver failure and portal hypertension in cirrhotic patients. | 1994 | 2 |
| 18 | 1990 | 1 | |
| 19 | 1990 | 1 | |
| 20 | Eicosanoid biosynthesis in human diabetes mellitus. | 1987 | 1 |
About P Alessandrini
P Alessandrini is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Surgery, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Inflammatory mediators and NSAID effects (5 papers), Cholesterol and Lipid Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Diabetes Treatment and Management (3 papers) and Free Radicals and Antioxidants (2 papers). The work is most often cited by research in Biochemistry (324 citations), Biochemistry (232 citations), Nutrition and Dietetics (424 citations), Endocrinology, Diabetes and Metabolism (364 citations) and Cardiology and Cardiovascular Medicine (295 citations). P Alessandrini has collaborated with scholars based in Italy, United States and Czechia. Frequent co-authors include Garret A. FitzGerald, Howard R. Knapp, Gabriele Bittolo Bon, Andrea Mezzetti, Tonino Bucciarelli, Giovanni Davı̀, Carlo Patrono, Giovanni Ciabattoni, Francesco Cipollone and Fabrizio Costantini. Their work appears in journals such as Circulation, Atherosclerosis, New England Journal of Medicine, European Journal of Pharmacology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.